Ponatinib Drugs Market

Ponatinib Drugs is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome?positive (Ph+) acute lymphoblastic leukemia(ALL).

Ponatinib Drugs Market contains market size and forecasts of Ponatinib Drugs in global, including the following market information:

• Global Ponatinib Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Ponatinib Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Ponatinib Drugs companies in 2021 (%)

The global Ponatinib Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

45mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Ponatinib Drugs include ARIAD Pharmaceuticals. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Ponatinib Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Ponatinib Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Ponatinib Drugs Market Segment Percentages, by Type, 2021 (%)

• 45mg
• 15mg

Global Ponatinib Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Ponatinib Drugs Market Segment Percentages, by Application, 2021 (%)

• CML
• ALL

Global Ponatinib Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Ponatinib Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Ponatinib Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Ponatinib Drugs revenues share in global market, 2021 (%)
• Key companies Ponatinib Drugs sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Ponatinib Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• ARIAD Pharmaceuticals